Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

NCT04152057 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2 Positive
Combination Chemotherapy

Interventions

DRUG: Pyrotinib Maleate Tablets
DRUG: Albumin Paclitaxel
DRUG: Trastuzumab

Sponsor

West China Hospital

Collaborators

[object Object]